Drug application
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM)
Drugs@FDA ANDA 201682 · IPCA LABS LTD
Key facts
| Drug name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM |
| Application type | ANDA |
| Application number | 201682 |
| Company | IPCA LABS LTD |
| Dosage forms | TABLET, ORAL |
| Strength | 12.5MG;50MG |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Mar 1, 2013 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.